2-Methylcitric acid l-1-yl)methyl]benzoic acid-d3 InChi: InChI=1S/C32H54N2O14/c35-29-8-9-30(36)34(29)48-31(37)10-12-39-14-16-41-18-20-43-22-24-45-26-27-46-25-23-44-21-19-42-17-15-40-13-11-33-32(38)47-28-6-4-2-1-3-5-7-28/h1-2

InChi: InChI=1S/C32H54N2O14/c35-29-8-9-30(36)34(29)48-31(37)10-12-39-14-16-41-18-20-43-22-24-45-26-27-46-25-23-44-21-19-42-17-15-40-13-11-33-32(38)47-28-6-4-2-1-3-5-7-28/h1-2

InChi: InChI=1S/C10H13N5/c1-7(2)3-4-11-9-8-10(13-5-12-8)15-6-14-9/h3

Thalidomide D4 is a deuterium labeled Thalidomide

Tipranavir was approved by the Food and Drug Administration (FDA) on June 22

4 are 20 min-1 and 77 µM

2-Methylcitric acid l-1-yl)methyl]benzoic acid-d3 InChi: InChI=1S/C32H54N2O14/c35-29-8-9-30(36)34(29)48-31(37)10-12-39-14-16-41-18-20-43-22-24-45-26-27-46-25-23-44-21-19-42-17-15-40-13-11-33-32(38)47-28-6-4-2-1-3-5-7-28/h1-22 Methylcitric acid (Methylcitric acid) is an endogenous metabolite in the 2 methylcitric acid cycle. 2 Methylcitric acid accumulates in methylmalonic and propionic acidemias and acts as a marker metabolite. 2 Methylcitric acid markedly inhibits ADP stimulated and uncoupled respiration in mitochondria supported by glutamate. Product information CAS Number: 6061 96 7 Molecular Weight: 206. 15 Formula: C7H10O7 Chemical Name: 2 hydroxy 1 methylpropane